Rheumatology Trials Seem Vulnerable to Unblinding: Report Rheumatology Trials Seem Vulnerable to Unblinding: Report

Until more is known about the potential for unblinding, clinicians need to keep in mind that patients and physicians could often guess accurately who was getting placebo or active drug.MDedge News

Source: Medscape Rheumatology Headlines - August 29, 2023 Category: Rheumatology Tags: Rheumatology Source Type: news